BRAF vs RAS oncogenes: Are mutations of the same pathway equal? Differential signalling and therapeutic implications | Oncotarget
Mutant KRAS can induce either BRAF/BRAF or BRAF-CRAF dimerazaiton of... | Download Scientific Diagram
Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia | Leukemia
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF Variants - ScienceDirect
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA | Nature Medicine
Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy - Decaussin‐Petrucci - 2017 - Cytopathology - Wiley Online Library
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Genes | Free Full-Text | Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks
Cancers | Free Full-Text | Atypical BRAF and NRAS Mutations in Mucosal Melanoma
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
Molecular targeted therapy of BRAF-mutant colorectal cancer - Michel Ducreux, Ali Chamseddine, Pierre Laurent-Puig, Cristina Smolenschi, Antoine Hollebecque, Peggy Dartigues, Emmanuelle Samallin, Valérie Boige, David Malka, Maximiliano Gelli, 2019
BRAF (gene) - Wikipedia
Význam vyšetření mutace BRAF u pacientů s melanomem | proLékaře.cz
Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy - Decaussin‐Petrucci - 2017 - Cytopathology - Wiley Online Library
Frontiers | Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution
Frontiers | The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
BRAF gene: From human cancers to developmental syndromes - ScienceDirect
MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories - ScienceDirect
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Frontiers | BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective
A) The RAS/BRAF/MEK/ERK and the PI3K/AKT/mTOR pathways and (B) their... | Download Scientific Diagram
Veterinary Sciences | Free Full-Text | Comparative Aspects of BRAF Mutations in Canine Cancers
